Value for Money: An Agenda for Global Health Funding Agencies

Share

Final report and related research

www.MoreHealthfortheMoney.org offers a quick and interactive way to read and share the Working Group's recommendations. 

Visit the Value for Money Initiative to see our latest work on this topic.

As international commitments become more ambitious and aid resources become increasingly constrained, global health funding agencies are seeking to improve the efficiency and impact of their investments. This growing “value for money” (VfM)  agenda aims to reduce costs, increase impact per dollar spent and focus investments on the highest impact interventions among the most affected populations.

The Center for Global Development (CGD) convened a working group to analyzed evidence, posed questions and came up with recommendations in four domains of a donors funding cycle: allocation, contracts, costs and spending, and performance verification. The group’s final report lays out a number of practical steps within each domain to improve value for money at the Global Fund to Fight AIDS, TB and Malaria.  These recommendations are also of relevance to other bilateral and multilateral funders, like the US President's Emergency Plan for AIDS Relief and the GAVI Alliance.

Members and Composition:

The Value for Money working group was chaired by Amanda Glassman, director of Global Health Policy and research fellow at CGD. Members of the Working Group were invited to join in a personal capacity and on a voluntary basis, and include experts from the public health sectors in developing and developed countries, technical and funding agencies, advocacy organizations and academia.

Working Group Members:

  • David Barr, Pangaea Global Aids Foundation
  • Joseph Brunet-Jailly, Institut de recherche pour le développement and Sciences-Po Paris
  • Kalipso Chalkidou, NICE International
  • Karl Dehne, UNAIDS
  • Alan Fairbank, Independent
  • Victoria Fan, CGD
  • Amanda Glassman, CGD, Working Group Chair
  • Kara Hanson, London School of Hygiene and Tropical Medicine
  • Iain Jones, DFID
  • Jason Lane, DFID
  • Bruno Meessen, Institute of Tropical Medicine
  • Mead Over, CGD
  • Nancy Padian, Independent
  • Mark Rilling, USAID
  • Josh  Salomon, Harvard School of Public Health
  • Nalinee Sangrujee, CDC
  • Nina Schwalbe, GAVI Alliance
  • Bernard Schwartlander, UNAIDS
  • David  Serwadda, Makerere University School of Public Health
  • Agnes Soucat, African Development Bank
  • Yot Teerawattananon, HiTAP
  • Damian Walker, Bill & Melinda Gates Foundation
  • Brenda Waning, UNITAID
  • David Wilson, World Bank
  • Prashant Yadav, University of Michigan
  • Gavin Yamey, UCSF

CGD Staff:

  • Denizhan Duran
  • Kate McQueston
  • Rachel Silverman

Contact:  Kate McQueston, KMcqueston@cgdev.org